“Comparison of the Effectiveness and Safety of Allopurinol and Febuxostat Use in CKD Patients with Hyperuricemia: A Systematic Review”, JFM, vol. 9, no. 1, pp. 157–162, Oct. 2026, doi: 10.35451/jfm.v9i1.3890.